NMRA vs PGR · $283.5M cap vs P/E 10, rev $87.67B
Neumora Therapeutics, Inc. (NMRA) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
NMRA does not have a complete income-statement cache yet.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
NMRA currently screens at market cap $283.5M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the NMRA and PGR stock pages for the full models.
Not investment advice.